ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
64.443,54
0,87%
Brent Oil
82,765
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Verona Pharma Plc (VRP)

  7. Verona Pharma Plc (VRP) Notícias

VRP

Verona Pharma (VRP)

Verona Pharma Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:VRP
DataHoraFonteTítuloCódigoCompanhia
02/02/202108:17UK RegulatoryVerona Pharma plc Correcting And Replacing -- Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifen...LSE:VRPVerona Pharma Plc
02/02/202104:00UK RegulatoryVerona Pharma plc Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifentrine In CopdLSE:VRPVerona Pharma Plc
14/01/202104:00UK RegulatoryVerona Pharma plc Verona Pharma Completes Enrollment In Pilot Study Of Pmdi Ensifentrine In U.S. Patients Hospitalized With C...LSE:VRPVerona Pharma Plc
05/01/202104:00UK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright Virtualbioconnect ConferenceLSE:VRPVerona Pharma Plc
23/11/202004:00UK RegulatoryVerona Pharma plc Verona Pharma Secures Up To $30 Million Debt Financing From Silicon Valley BankLSE:VRPVerona Pharma Plc
09/11/202004:00UK RegulatoryVerona Pharma plc Verona Pharma Announces November 2020 Virtual Investor Conference ParticipationLSE:VRPVerona Pharma Plc
30/10/202004:00UK RegulatoryAIM Cancellation - Verona Pharma PLCLSE:VRPVerona Pharma Plc
29/10/202016:09Alliance NewsAlliance NewsIN BRIEF: Verona Pharma Says Third Quarter Loss WidensLSE:VRPVerona Pharma Plc
29/10/202004:00UK RegulatoryVerona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Three And Nine Months Ended September30,...LSE:VRPVerona Pharma Plc
28/10/202008:01UK RegulatoryVerona Pharma plc Verona Pharma Plc : Update On Aim DelistingLSE:VRPVerona Pharma Plc
23/10/202013:30UK RegulatoryFTSE Russell Verona PharmaLSE:VRPVerona Pharma Plc
22/10/202003:00UK RegulatoryVerona Pharma plc Verona Pharma To Announce Interim Results For The Three And Nine Months Ended September 30, 2020 And Provid...LSE:VRPVerona Pharma Plc
13/10/202003:00UK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Copd Symptom And Quality Of Life Data With Ensifentrine At Chest 2020LSE:VRPVerona Pharma Plc
23/09/202005:06UK RegulatoryVerona Pharma plc Verona Pharma Initiates Phase 3 Clinical Trials With Nebulized Ensifentrine For The Maintenance Treatment O...LSE:VRPVerona Pharma Plc
21/09/202010:12Alliance NewsAlliance NewsIN BRIEF: Verona Pharma To Delist From AIM But Remain On NasdaqLSE:VRPVerona Pharma Plc
21/09/202003:00UK RegulatoryVerona Pharma plc Intended Delisting And Cancellation Of Ordinary Shares From Trading On AimLSE:VRPVerona Pharma Plc
17/09/202003:00UK RegulatoryVerona Pharma plc Verona Pharma To Ring The Nasdaq Closing Bell To Celebrate $200 Million FinancingLSE:VRPVerona Pharma Plc
16/09/202009:25UK RegulatoryVerona Pharma plc Verona Pharma Announces Publication Of Phase 2b Copd Symptom Data In The International Journal Of Chronic O...LSE:VRPVerona Pharma Plc
08/09/202003:00UK RegulatoryVerona Pharma plc Verona Pharma Initiates Pilot Study With Pmdi Ensifentrine In U.S. Patients Hospitalized With Covid-19LSE:VRPVerona Pharma Plc
02/09/202003:00UK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright 22nd Annual Global Virtual Investment ConferenceLSE:VRPVerona Pharma Plc
26/08/202006:19UK RegulatoryVerona Pharma plc Verona Pharma Plc: Grant Of Radsus And Pdmr DealingsLSE:VRPVerona Pharma Plc
24/08/202007:09Alliance NewsAlliance NewsVerona Pharma Says Study Shows Ensifentrine Improves Lung FunctionLSE:VRPVerona Pharma Plc
24/08/202003:00UK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Data With Ensifentrine In Copd At The European Respiratory Society Intern...LSE:VRPVerona Pharma Plc
19/08/202006:35Alliance NewsAlliance NewsVerona Pharma Makes Progress In Phase Two Of Inhaler Clinical TrialLSE:VRPVerona Pharma Plc
19/08/202003:00UK RegulatoryVerona Pharma plc Verona Pharma Initiates Multiple Dose Part Of Phase 2 Clinical Trial With Pmdi Formulation Of Ensifentrine ...LSE:VRPVerona Pharma Plc
14/08/202007:05UK RegulatoryVerona Pharma PLC Second Price Monitoring ExtnLSE:VRPVerona Pharma Plc
14/08/202007:00UK RegulatoryVerona Pharma PLC Price Monitoring ExtensionLSE:VRPVerona Pharma Plc
14/08/202005:22Alliance NewsAlliance NewsVerona To Trial Ensifentrine For Covid-19; First Half Loss WidensLSE:VRPVerona Pharma Plc
14/08/202003:00UK RegulatoryVerona Pharma plc Verona Pharma Plcoperational Update And Financial Results For The Three And Six Months Ended June30, 2020LSE:VRPVerona Pharma Plc
07/08/202011:46UK RegulatoryVerona Pharma plc Verona Pharma Plc: Tr-1: Standard Form For Notification Of Major HoldingsLSE:VRPVerona Pharma Plc
 Apresentando as notícias mais relevantes sobre:LSE:VRP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
BOV
PRIO3
PETRORIO ON
BOV
HETA4
HERCULES PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados